Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PPQ for Malaria Prevention in HIV-infected Pregnant Women
NCT03671109Phase 3Completed
- Sponsor
- Barcelona Institute for Global Health
- Start
- Sep 2019
- Primary completion
- Jul 2022
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Barcelona Institute for Global Health. Started Sep 2019; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03671109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671109.